Cirkulerende tumor-DNA ved behandling af kræft

Cecilie Riis Iden, Amanda Frydendahl Boll Johansen, Nadia Øgaard, Iben Boutrup Kongsfelt, Kristian Egebjerg, Claus Lindbjerg Andersen, Morten Mau-Sørensen*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

14 Downloads (Pure)

Abstract

Circulating tumour DNA analysis has a potential to improve multiple aspects of cancer management. This includes: a) early cancer detection in asymptomatic individuals, b) identification of patients with residual disease after curative intended treatment, c) patient stratification in relation to treatment decisions like adjuvant therapy and intensity of radiological surveillance, d) monitoring treatment effect for optimised adaptive therapy, e) identification of actionable targets, and f) early recurrence detection. These points are summarised in this review

Bidragets oversatte titelCirculating tumour DNA in the treatment of cancer
OriginalsprogDansk
ArtikelnummerV02210154
TidsskriftUgeskrift for Læger
Vol/bind183
Nummer2
Antal sider8
ISSN0041-5782
StatusUdgivet - jan. 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cirkulerende tumor-DNA ved behandling af kræft'. Sammen danner de et unikt fingeraftryk.

Citationsformater